Pancreatic Safety of Sitagliptin in the TECOS Study

OBJECTIVE: We evaluated the incidence of acute pancreatitis and pancreatic cancer in patients with type 2 diabetes and cardiovascular disease who were treated with sitagliptin, a dipeptidyl peptidase-4 inhibitor (DPP-4i). RESEARCH DESIGN AND METHODS: In the Trial Evaluating Cardiovascular Outcomes w...

詳細記述

保存先:
書誌詳細
出版年:Diabetes Care
主要な著者: Buse, John B., Bethel, M. Angelyn, Green, Jennifer B., Stevens, Susanna R., Lokhnygina, Yuliya, Aschner, Pablo, Grado, Carlos Raffo, Tankova, Tsvetalina, Wainstein, Julio, Josse, Robert, Lachin, John M., Engel, Samuel S., Patel, Keyur, Peterson, Eric D., Holman, Rury R.
フォーマット: Artigo
言語:Inglês
出版事項: American Diabetes Association 2017
主題:
Clinical Care/Education/Nutrition/Psychosocial Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5864139/
https://ncbi.nlm.nih.gov/pubmed/27630212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc15-2780
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料